[1] 向川.软骨细胞凋亡与骨关节炎[J].国外医学:免疫学分册,2003, 26(2):110-111.
[2] 林木南,刘献祥.透骨消痛方治疗膝骨性关节炎30例[J].福建中医药,2005,36(4):15-16.
[3] 李民,陈文列,刘献祥,等.透骨消痛胶囊干预膝骨性关节炎软骨下骨重塑分子机制探讨[J].福建中医学院学报,2009,19(6):35-39.
[4] 吴广文,叶锦霞,郑春松,等.骨性关节炎模型大鼠关节软骨变化及透骨消痛胶囊干预的作用[J].中国组织工程研究, 2015,18(49): 7924-7929.
[5] 吴广文,叶锦霞,许惠凤,等.透骨消痛胶囊对KOA大鼠关节软骨uPA系统相关调节因子的影响[J].世界中西医结合杂志, 2015, 10(1):22-26.
[6] 李西海,刘献祥.透骨消痛胶囊含药血清干预软骨细胞周期与凋亡的实验研究[D].福建:福建中医药大学骨伤学院.2010.
[7] 黄继汗,黄晓晖,陈志扬,等.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069.
[8] 袁琴,阚卫兵,宋朋飞,等补肾活血方对大鼠膝骨关节炎滑膜细胞β-catenin、MMP-7的影响[J].中国骨伤,2012,25(9):761-765.
[9] Liu L, Ishijima M, Futami I, et al.Correlation between synovitis detected on enhanced-magnetic resonance imaging and a histological analysis with a patient-oriented outcome measure for Japanese patients with end-stage knee osteoarthritis receiving joint replacement surgery. Clin Rheumatol. 2010; 29(10):1185-1190.
[10] 汤继文,刘新宇.骨关节病的诊治[J].山东医药, 2000,40(15): 43-44.
[11] Hayashi D, Roemer FW, Katur A, et al.Imaging of Synovitis in Osteoarthritis: Current Status and Outlook. Semin Arthritis Rheum. 2011;41(2):116-130.
[12] Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6(11):625-635.
[13] Havdrup T, Telhag H. Papain-induced changes in the knee joints of adult rabbits. Acta Orthop Scand. 1977;48(2):143-149.
[14] Kopp S, Mejersj? C, Clemenssson E. Induction of osteoarthrosis in the guinea pig knee by papain. Oral Surg Oral Med Oral Pathol.1983;55(3):259-266.
[15] Marcelon G, Cros J, Guiraud R. Experimental model of osteoarthritis. Agents Actions.1976;6(1-3):191-194.
[16] Murat N, Karadam B, Ozkal S, et al. Quantification of papain-induced rat osteoarthritis in relation to time with the Mankin score. Acta Orthop Traumatol Turc. 2007;41(3): 233-237,2007.
[17] 杨春花,黄烽.类风湿关节炎中尿激酶型纤溶酶原激活剂的作用机制及其临床意义[J].中华风湿病学杂志,1999,3(4):72-74.
[18] Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondroeytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum. 2001;44(3):585-594.
[19] Lijnen HR. Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry(Mosc). 2002;67(1):92-98.
[20] 周江涛,刘献祥.骨性关节炎软骨破坏机制及治疗研究进展[J].中医正骨,2004,16(11):56-58.
[21] Hulejova H, Baresova V, Klezl Z, et al. Increased level of cytokines and matrix metalloproteinase in osteoarthritic subchondral bone. Cytokine. 2007;38:151-156.
[22] 张铁锋,李景峰.细胞因子IL-1β和TNF-α在骨关节炎软骨中mRNA表达的变化及意义[J].中国现代医生,2008,46(15): 116-117.
[23] 李捷一,刘芳.膝关节骨性关节炎患者关节液中TNF-α与NO的检测[J].中国现代手术学杂志,2008,12(1):6-8.
[24] 陈智能,杨连梓.滑膜性病变与骨性关节炎[J].福建中医学院学报, 2003,13(4):53.
|